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Abstract
Background: A high quality decision requires that patients who meet clinical criteria for surgery are informed
about the options (including non-surgical alternatives) and receive treatments that match their goals. The aim of
this study was to evaluate the psychometric properties and clinical sensibility of a patient self report instrument, to
measure the quality of decisions about total joint replacement for knee or hip osteoarthritis.
Methods: The performance of the Hip/Knee Osteoarthritis Decision Quality Instrument (HK-DQI) was evaluated in
two samples: (1) a cross-sectional mail survey with 489 patients and 77 providers (study 1); and (2) a randomized
controlled trial of a patient decision aid with 138 osteoarthritis patients considering total joint replacement (study
2). The HK-DQI results in two scores. Knowledge items are summed to create a total knowledge score, and a set of
goals and concerns are used in a logistic regression model to develop a concordance score. The concordance
score measures the proportion of patients whose treatment matched their goals. Hypotheses related to
acceptability, feasibility, reliability and validity of the knowledge and concordance scores were examined.
Results: In study 1, the HK-DQI was completed by 382 patients (79%) and 45 providers (58%), and in study 2 by 127
patients (92%), with low rates of missing data. The DQI-knowledge score was reproducible (ICC = 0.81) and
demonstrated discriminant validity (68% decision aid vs. 54% control, and 78% providers vs. 61% patients) and content
validity. The concordance score demonstrated predictive validity, as patients whose treatments were concordant with
their goals had more confidence and less regret with their decision compared to those who did not.
Conclusions: The HK-DQI is feasible and acceptable to patients. It can be used to assess whether patients with
osteoarthritis are making informed decisions about surgery that are concordant with their goals.
Keywords: shared decision making, patient centered care, quality measurement, osteoarthritis, total joint replace-
ment, decision quality
Background
The decision to undergo total joint replacement (TJR)
for treatment of osteoarthritis can be difficult. The indi-
cations for surgery are not solely determined based on
clinical features such as imaging or extent of disease;
rather, providers need to work with their patients to
consider how bothered patients are by their symptoms,
and discuss their goals and concerns regarding
treatment for their joint pain. Clinicians, consumers and
researchers have recognized the “patient-centered” nat-
ure of these and other common preference-sensitive
medical decisions and the importance of shared decision
making to ensure high quality decisions [1-3].
For patient-centered care, providers need to ensure
that patients are well informed and that medically
appropriate treatments address patients’ needs, wants
and preferences [4]. Decision quality is an important
indicator of patient-centered care and an outcome
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tional Patient Decision Aids Standards reached consen-
sus on a definition of decision quality as “the match
between the chosen option and the features that matter
most to the informed patient” [6]. The definition
emphasizes two key imperatives, 1) patients are
informed with the best available evidence and 2) there is
concordance between what matters most to patients and
the treatments they receive.
A comprehensive assessment of decision quality
requires assessing patients’ knowledge, the extent to
which the treatment they receive matches their goals
and concerns about surgical and non surgical treat-
ments[2,7]. We found one published instrument that
assessed knowledge of treatments for osteoarthritis [8],
but none that assessed the extent to which treatments
for osteoarthritis matched patients’ goals. There is a lack
of published, reliable measures that can be used to
assess decision quality for patients with osteoarthritis.
Sound survey instruments must satisfy several criteria
including strong psychometric properties (e.g., reliability
and validity) and clinical sensibility (e.g., acceptability
and feasibility) [9]. The purpose of this study is to
examine performance of the Hip/Knee Osteoarthritis
Decision Quality Instrument (HK-DQI) along these cri-
teria using two study samples. The first study was a ret-
rospective survey of patients who had made a treatment
decision within the past two years and who were able to
reflect on the outcomes of treatments (either surgical or
non surgical). It also surveyed their providers. The sec-
ond study used the HK-DQI in a randomized controlled
trial of a patient decision aid with patients currently
facing a decision about total joint replacement. These
samples provide complementary data on the perfor-
mance of the instrument. The retrospective patient sam-
ple provided an “experienced” sample to evaluate the
items and to examine stability of the responses. The
randomized trial assessed decision quality prospectively
and could examine ability of the instrument to discrimi-
nate between those who had decision aid or not.
Methods
The development of the Hip/Knee Osteoarthritis Deci-
sion Quality Instrument followed an extensive process
that has been used to develop decision quality instru-
ments for several common medical decisions [2,10].
First, there was a rigorous review of the published clini-
cal evidence regarding treatment of osteoarthritis, and
this was supplemented with findings from focus groups
of patients with hip and knee osteoarthritis. A set of
facts essential for making an informed decision and a
set of goals salient for the decision were generated and
then rated by a convenience sample of osteoarthritis
patients (n = 88) and a multidisciplinary group of
clinical experts (n = 51) [10]. Experts in survey research
methods subsequently drafted questions for key facts
and goals. Cognitive interviews were conducted with
osteoarthritis patients (n = 10) where patients complete
the survey while and interviewer watches, and then
patients describe their understanding of the question
and their answers to an interviewer. Based on the
results, revisions were made the questions to improve
acceptability and comprehensibility.
Samples and procedures
Study 1
A survey was conducted in the U.S. with adults aged 40
years and older with hip or knee osteoarthritis who
either had joint replacement surgery or had discussed
surgery with their physician (and chose not to have it),
within the past two years. Individuals with bilateral knee
surgery, osteonecrosis, partial knee replacement, psoria-
tic arthritis, revision surgery, or rheumatoid arthritis,
were excluded. Patients were recruited via patient regis-
tries at three academic hospitals and via newspaper ads.
Eligible participants were selected for the sample to
reach a minimum of 100 patients in key subgroups
including type of osteoarthritis (hip or knee) and treat-
ment (surgical or nonsurgical). Patients were mailed the
HK-DQI, completed the paper instrument at home and
returned it by mail. Non-respondents received a remin-
der phone call at two weeks and a reminder packet that
included the original survey at four weeks. A subset of
patients received a retest packet 4-6 weeks after com-
pleting their initial survey. A small gift (valued at $10
US) was provided with the initial mailing and for each
completed survey.
The approach used to determine sample size for valid-
ity testing followed that advocated by Fowler [11]. First,
we developed an analysis plan and identified key sub-
groups (joint (hip vs. knee) and treatment (surgical vs.
non surgical)) and then estimated how large a sample
was needed in order to reach minimum targets in the
smaller subgroups. A minimum of 100 respondents in
each subgroup ensured adequate power for these ana-
lyses (including sufficient observations to incorporate all
key variables into the concordance model).
Primary care physicians, orthopedic surgeons, and
nurses who treated patients recruited from each of the
three sites were mailed a study packet with a $10 incen-
tive. Phone or email reminders were sent at two weeks
and a mailed reminder packet that included the original
survey at four weeks. Providers at some sites received a
$40 gift card for completing the survey.
Study 2
Adult patients with osteoarthritis of the hip or knee who
met the guidelines for referral to an orthopaedic sur-
geon for TJR and had access to a TV with a VCR or
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with inflammatory arthritis; a previous total joint repla-
cement; or who were deaf, blind, cognitively impaired,
or had a language barrier were excluded [12]. After sign-
ing a consent form, patients were randomized to receive
either a patient decision aid on TJR or usual care.
Patients allocated to the usual care group received a
standard information booklet prepared by the hospital
for patients undergoing joint replacement. The decision
aid group received the same information booklet and a
decision aid (video/DVD and booklet) titled Treatment
Choices for Knee Osteoarthritis (©Health Dialog and
Foundation for Informed Medical Decision Making,
2007). The decision aid describes osteoarthritis and the
different treatment options and includes interviews with
patients who discuss their experiences using surgical
and non surgical approaches to managing their disease.
Both groups were instructed to review the information
at home and complete the HK-DQI. Approximately one
week after recruitment, a research assistant telephoned
participants to record the answers to the HK-DQI over
the phone. The research assistant made an average of
four calls to participants to complete the survey. Sample
size for study 2 was calculated based on the primary
outcome of wait time for surgery (Trials Registration #
NCT00911638).
The study protocols were approved by the Institu-
tional Review Boards at the participating sites. The pro-
cedures followed were in accordance with the ethical
standards of the responsible committee on human
experimentation (institutional and national) and with
the Helsinki Declaration of 1975, as revised in 2000.
Measures
The HK-DQI was administered in both studies along
with general questions about demographics, treatments
received and severity of osteoarthritis.
HK-DQI
The Hip and Knee instruments were almost identical
(with the word “hip” replaced for “knee”) and contained
two main sections. The instrument is available from the
corresponding author (ksepucha@partners.org).
1. Knowledge: 9 multiple choice and open-ended
questions scored as correct or incorrect.
2. Goals and concerns: 7 items rated on an impor-
tance scale from 0 (not at all important) to 10 (extre-
mely important).
Treatment preference
Assessed with a single item, “Which option was your
personal preference?” with responses “Non-surgical
approaches”, “Surgery”,o r“I’m not sure”.
Osteoarthritis severity
Patients completed 5 items from the Western Ontario
McMasters University Osteoarthritis Index (WOMAC)
pain subscale. The subscale has been used extensively
for hip and knee osteoarthritis and scores range from 0
(least) to 20 (most) pain [13].
Study 1 included the following additional items in the
patient questionnaire:
Top Three Goals and Concerns
Patients were asked to indicate the top three goals and
concerns from those included in the HK-DQI.
Confidence
Assessed with a single item, “On a scale of 0 (not at all)
to 10 (extremely), how confident are you that the deci-
sion about surgery was the right one for you?”
Regret
Assessed with a single item, “If you had the chance to
do it again, would you make the same decision about
surgery?” with responses of definitely yes, probably yes,
not sure, probably no and definitely no.
Provider Measures (Study 1)
Providers completed the HK-DQI knowledge questions
and two other questions to confirm content validity: 1)
“Overall, how well does this set of items represent the
key facts that patients should know before making a
decision about surgery for [hip/knee] replacement?”
with responses: Extremely well, very well, somewhat
well, not at all well; and 2) “For each item please indi-
cate whether you feel it is essential, very important or
not important for patients to understand in order to be
considered informed.”
Statistical Analysis
Item Retention and Deletion
A steering group that included experts in survey
research, decision sciences and clinical experts in
osteoarthritis examined items for issues such as diffi-
culty (e.g., too easy or too hard), problematic format (e.
g., multiple responses checked off when only one was
expected), redundancy, and floor or ceiling effects (e.g.,
responses bunched at the bottom or top of the scale).
DQI- Knowledge Score
Each correct response received 1 point. Single items
with multiple components had the individual compo-
nent scores weighted equally in the total possible score
of 1 for that item. The response, “Ia mn o ts u r e , ” was
considered incorrect. The score was standardized by
dividing the number of correct responses by the number
of items, resulting in mean scores from 0% to 100%. A
knowledge score was calculated for all respondents who
completed at least 50% of the items.
DQI-Concordance Score
This approach follows that used by Barry et al (1995) to
examine the extent to which patients’ goals are asso-
ciated with treatments [14]. We examined whether hav-
ing TJR or not was associated with selected patient
characteristics (e.g. age, gender), joint (knee or hip), and
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continuous variables and Chi-Squared tests for categori-
cal variables) and in multivariate analysis using a logistic
regression model with treatment received (surgery vs.
non-surgical) as the dependent variable. The regression
model generated a predicted probability of surgery for
each patient. Patients with a predicted probability >0.5
and who had surgery or those with a predicted probabil-
ity ≤0.5 and who did not have surgery, were classified as
having treatments that “matched” their goals. This
yielded a summary concordance score that indicated the
percentage of patients whose decisions “matched” their
goals. Higher scores indicate that more patients are
receiving treatments that match their goals.
Clinical Sensibility of the Instrument
Acceptability and Feasibility
Acceptability was examined using length of time to
complete the instrument, which was self-reported by
patients, and response rates. Feasibility was examined
using rates of missing data, with any item with more
than 5% missing responses considered problematic and
any mode of administration (e.g. paper or phone) with
consistently high missing data (average >5%) would be
considered not feasible.
Psychometric Evaluation
Reliability
Test-retest reliability was assessed by calculating the
intraclass correlation coefficient (ICC) for the total
knowledge score and for the individual goals and con-
cerns. For the respondents in study 1, the scores were
not expected to change over the four- to six-week per-
iod, so the target was to exceed 0.7 in that sample. We
selected a 4 to 6 week retest period as that would be
long enough that respondents would not remember
their responses and short enough that they would be
likely to complete the survey. Cronbach’s alpha was not
used as a measure of internal consistency for the knowl-
edge score, as the set of knowledge items is not a mea-
sure of one underlying construct.
Validity
T h e r ei sn og o l ds t a n d a r df o rm e a s u r i n gk n o w l e d g e ,
goals and concerns, or concordance so the following
hypotheses relating to validity were examined:
Knowledge Score
(1) Discriminant validity: A key feature of a knowl-
edge test is that it can discriminate among those
with different levels of knowledge and can detect
clinically meaningful differences in knowledge result-
ing from interventions. As a result, we tested
hypotheses that (a) providers would have higher
knowledge scores than patients and that (b) patients
who had seen a decision aid would have higher
knowledge than the control group, using two sample
t-tests.
(2) Content validity: we examined the proportion of
providers who considered the knowledge items
essential or very important.
Concordance Score
The validity of the concordance score was examined
three different ways. First, we examined the content
validity of the goals which are the key inputs to the
model. Next, we tested the discriminant validity of
the regression model by examining whether it could
distinguish between patients who stated a preference
for surgery or non surgical treatments. Finally, we
t e s t e dt h ep r e d i c t i v ev a l i d i t yo ft h es c o r ei t s e l fb y
examining its relationship to decision confidence and
regret.
(1) Content validity of the goals: We examined how
many surgical and non-surgical patients selected
each goal as one of their top three issues. If a small
proportion of patients included an item (fewer than
20%) then we would consider deleting the item for
low content validity.
(2) Discriminant validity: The regression model gen-
erates a predicted probability for surgery. Our
hypothesis was that patients who stated a preference
for surgery would have a higher predicted probability
of having surgery based on the multivariate regres-
sion model, compared to those who were unsure.
M o r e o v e r ,t h o s ew h ow e r eu n s u r ew o u l dh a v ea
higher predicted probability than those who stated a
preference for non-surgical approaches. These
hypotheses were tested using ANOVA with planned
comparisons.
(3) Predictive validity: The concordance score indi-
cates the proportion of patients who received treat-
ments that matched their goals. To test the
predictive validity of the score, we hypothesized that
patients who received treatments that matched those
predicted by the regression model would have higher
confidence (using a two sample t-test) and less
regret (using a Chi squared test) than those who did
not match.
HK-DQI Screener version
A shorter version of the instrument was evaluated that
included 5 knowledge items (items indicated in
Table 1). We examined discriminant validity of this ver-
sion and also examined how well it correlated with the
full score.
Analyses of study 1 data were conducted using PASW
Statistics 18.0. Analyses of study 2 were conducted
using SAS 9.1.
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Response Rates and Sample
The overall patient response rates were 79% and 92% for
studies 1 and 2, respectively. The patient response rate
for the retest survey in study 1 was 83%. Patient charac-
teristics were similar across studies and are summarized
in Table 1. Data on age and gender were available for
non responders in study 1. Responders tended to be
slightly older than non responders (mean age 62.7 vs.
60.4, p = 0.03). There was no difference in response
rates by gender.
T h ep r o v i d e rr e s p o n s er a t ew a s5 8 % .T h ep r o v i d e r
sample was on average, 50 years old and 68% were
male. Forty-one percent were primary care doctors, 39%
were orthopedic surgeons and the rest were nurses. The
providers had been in practice a median of 21 years and
saw a median of 100 patients with osteoarthritis each
year.
Item Retention and Deletion
One knowledge item (on usefulness of imaging) was
deleted for being too difficult (only 43% of providers
answered correctly). The patients’ total knowledge
scores ranged from 0-100% with no evidence of a floor
or ceiling effect in either study. Although the responses
for the goals and concerns also spanned the entire range
(0 to 10) for each item, two had evidence of a ceiling
effect. For “relieve pain,” and “not be limited in what
you can do,” 71% and 77%, respectively, selected 10 out
of 10 (or extremely important). The remaining analyses
were conducted with the reduced set of 8 knowledge
items and the full set of 7 goals and concerns. The
knowledge items and responses are in Table 2 and the
full survey instrument is available from the correspond-
ing author.
Acceptability and Feasibility
The response rates were high when administered by
mail (79%, study 1) and by phone (92%, study 2). In
study 1, respondents self-reported taking an average of
4.5 minutes to complete the HK-DQI (range 2-22 min-
utes). The mean number of missing responses was low
when administered by mail or phone (1.6% and 0.08%,
respectively for knowledge items) and (1.4% and 0.10%,
respectively for the goals).
Reliability
The retest reliability for the total knowledge score was
ICC = 0.83 (95% CI 0.75 to 0.89). The retest reliability
of the goals and concerns was acceptable: relieve pain
(ICC = 0.81), avoid surgery (ICC = 0.80), not be limited
in what you can do (ICC = 0.74), avoid over the counter
Table 1 Demographic characteristics of patient respondents for each study.
Study 1 Study 2
Characteristic Patients
N = 382
Control group
N=6 6
Decision aid group
N=6 1
Gender: Male (%) 169 (44) 27 (40.9) 25 (40.9)
Age mean (SD) 62.7 (9.6) 66.1 (9.49) 64.3 (10.16)
Race/ethnicity (%)
White 359 (95.5) N/A N/A
Education (%)
≥ College graduate 209 (56) 40 (60.6) 39 (63.9)
Some college 94 (25.2) N/A N/A
High school or less 68 (18.1) 26 (39.4) 22 (36.1)
Missing 9 (2.4) 0 0
Income (%)
<$30,000 78 (20.5) 5 (7.6)* 7 (11.5)*
$30,000-60,000 70 (18.3) 21 (31.8)** 18 (29.5)**
$60,000-100,000 89 (23.3) 13 (19.7) 21 (34.4)
Over $100,000 93 (24.3) 22 (33.3) 12 (19.7)
Missing 52 (13.6) 5 (7.6) 3 (4.9)
Married/Committed relationship (%) 255 (67.8) 42 (63.6) 38 (62.3)
Months since decision (median, IQR) 11 (7, 15) Considering decision Considering decision
Had (or preferred) Surgery (%) 235 (61)
Had surgery
49 (74.2)
Preferred surgery
39 (63.9)
Preferred surgery
Joint: Knee (%) 201 (53) 61 (94) 59 (97)
WOMAC Pain Score mean (SD) 5.6 (4.6) 10.7 (4.2) 11.2 (4.0)
SD = standard deviation; N/A = not asked; FT = fulltime; IQR: interquartile range; * measured < $20,000; ** measured from $20,000; WOMAC = Western Ontario
McMasters University Arthiritis Index
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providers across the two studies.
Study 1 Study 2
Patients Providers Control Decision Aid
Item N(%) N(%) N(%) N(%)
†1. Over time, without surgery, what usually happens to the pain from hip/knee osteoarthritis?
Gets better 2 (0.5) 4 (4.4) 1 (1.5) 2 (3.3)
Stays about the same 15 (3.9) 5 (5.6) 3 (4.5) 6 (9.8)
* Gets worse 344 (90) 78 (86.7) 59 (89.4) 52 (85.2)
Not sure 17 (4.5) 2 (2.2) 3 (4.5) 1 (1.6)
Missing 2 (0.5) 1 (1.1) 0 (0) 0 (0)
2. For each of the following, please mark whether or not it can help relieve the pain of hip/knee osteoarthritis.
a. Exercise
*Yes 217 (56.8) 65 (72.2) 51 (77.3) 57 (93.4)
No 105 (27.5) 18 (20) 7 (10.6) 4 (6.6)
Not sure 53 (13.9) 5 (5.6) 8 (12.1) 0 (0)
Missing 6 (1.6) 2 (2.2) 0 (0) 0 (0)
b. Physical therapy
*Yes 229 (59.9) 71 (78.8) 50 (75.8) 54 (88.5)
No 87 (22.8) 13 (14.4) 6 (9.1) 5 (8.2)
Not sure 61 (16.0) 5 (5.6) 10 (15.2) 2 (3.3)
Missing 5 (1.3) 1 (1.1) 0 (0) 0 (0)
c. Staying off the leg
*Yes 162 (42.4) 58 (64.4) 36 (54.5) 39 (63.9)
No 150 (39.3) 23 (25.6) 22 (33.3) 19 (31.1)
Not sure 61 (16) 8 (8.9) 7 (10.6) 3 (4.9)
Missing 9 (2.3) 1 (1.1) 1 (1.5) 0 (0)
d. Over-the-counter pain medicine
*Yes 257 (67.3) 87 (96.7) 50 (75.8) 50 (82.0)
No 70 (18.6) 0 (0) 10 (15.2) 6 (9.8)
Not sure 48 (12.6) 2 (2.2) 5 (7.6) 5 (8.2)
Missing 6 (1.6) 1 (1.1) 1 (1.5) 0 (0)
†3. After hip/knee replacement surgery, about how many months does it take most people to get back to doing their usual activities?
Less than 1 month 2 (0.5) 1 (1.1) 1 (1.5) 0 (0)
1 to 2 months 75 (19.6) 22 (24.4) 14 (21.2) 7 (11.5)
*3 to 9 months 236 (61.8) 57 (63.3) 27 (40.9) 44 (72.1)
More than 9 months 34 (8.9) 9 (10.0) 6 (9.1) 7 (11.5)
Not sure 31 (8.1) 0 (0) 18 (27.3) 3 (4.9)
Missing 3 (0.8) 1 (1.1) 0 (0) 0 (0)
†4. About how many people who have hip/knee replacement surgery will need to have the same hip/knee replaced again in less than 15 years?
More than half 28 (7.3) 1 (1.1) 8 (12.1) 5 (8.2)
About half 49 (12.8) 5 (5.6) 7 (10.6) 7 (11.5)
*Less than half 79 (20.7) 39 (43.3) 15 (22.7) 15 (24.6)
*Almost none 103 (27) 43 (47.8) 12 (18.2) 26 (42.6)
Not sure 115 (30) 0 (0) 24 (36.4) 8 (13.1)
Missing 4 (1.0) 2 (2.2) 0 (0) 0 (0)
†5. If 100 people have hip/knee replacement surgery, about how many will have less hip/knee pain when walking after the surgery?
0-25 10 (2.6) 0 (0) 1 (1.5) 2 (3.3)
26-50 6 (1.6) 3 (3.3) 2 (3.0) 1 (1.6)
51-75 54 (14.1) 12 (13.3) 5 (7.6) 3 (4.9)
*76-100 251 (65.7) 72 (80.0) 38 (57.6) 47 (77.0)
Not sure 57 (14.9) 3 (0) 20 (30.3) 8 (13.1)
Missing 3 (.8) 3 (3.3) 0 (0) 0 (0)
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providers across the two studies. (Continued)
†6. Serious complications can happen after hip/knee replacement surgery, such as death, life-threatening blood clots, infection and heart attack. Out
of 100 people who have hip/knee replacement surgery, about how many will have a serious complication within the three months after the
surgery?
*Fewer than 5 164 (42.9) 62 (68.9) 29 (43.9) 45 (73.8)
5-10 64 (16.8) 18 (20.0) 7 (10.6) 5 (8.2)
11-15 20 (5.2) 9 (10.0) 3 (4.5) 1 (1.6)
More than 15 9 (2.4) 1 (1.1) 2 (3.0) 1 (1.6)
Not sure 115 (30.1) 0 (0) 25 (37.9) 9 (14.8)
Missing 10 (2.6) 0 (0) 0 (0) 0 (0)
7. For each of the following, mark whether or not it is a possible complication of hip/knee replacement surgery.
a. Stomach ulcers
*Yes 32 (8.4) 59 (65.6) 4 (6.1) 14 (23.0)
No 209 (54.7) 25 (27.8) 40 (60.6) 35 (57.4))
Not sure 126 (33) 5 (5.6) 22 (33.3) 12 (19.7)
Missing 15 (3.9) 1 (1.1) 0 (0) 0 (0)
b. Blood clot in the leg
*Yes 332 (86.9) 45 (100.0) 51 (77.3) 52 (85.2)
No 7 (1.8) 0 (0) 3 (4.5) 3 (4.9)
Not sure 34 (8.9) 0 (0) 12 (18.2) 6 (9.8)
Missing 8 (2.1) 0 (0) 0 (0) 0 (0)
c. Migraine headaches
Yes 21 (5.5) 9 (10.0) 5 (7.6) 4 (6.6)
*No 210 (55) 62 (68.9) 36 (54.5) 40 (65.6)
Not sure 135 (35.3) 18 (20.0) 25 (37.9) 17 (27.9)
Missing 16 (4.2) 1 (1.1) 0 (0) 0 (0)
d. Infection of the artificial hip/knee
*Yes 279 (84.8) 45 (100.0) 51 (77.3) 51 (83.6)
No 9 (2.7) 0 (0) 1 (1.5) 2 (3.3)
Not sure 30 (9.1) 0 (0) 14 (21.2) 8 (13.1)
Missing 9 (2.7) 0 (0) 0 (0) 0 (0)
8. For each of the following, mark whether or not it is a possible side effect of using over-the-counter pain medicine for a long time. These include
medicines you can buy without a prescription like Advil, Aleve or aspirin.
a. Stomach ulcer
*Yes 320 (83.8) 45 (100.0) 56 (84.8) 58 (95.1)
No 10 (2.6) 0 (0) 3 (4.5) 1 (1.6)
Not sure 40 (10.5) 0 (0) 7 (10.6) 2 (3.3)
Missing 12 (3.1) 0 (0) 0 (0) 0 (0)
b. Blood clot in the leg
Yes 59 (15.4) 5 (5.6) 11 (16.7) 18 (29.5)
*No 171 (44.8) 81 (90.0) 29 (43.9) 32 (52.5)
Not sure 137 (35.9) 2 (2.2) 26 (39.4) 11 (18.0)
Missing 13 (3.4) 2 (2.2) 0 (0) 0 (0)
c. Migraine headaches
Yes 42 (11) 23 (25.5) 8 (12.1) 12 (19.7)
*No 164 (42.9) 48 (53.3) 28 (42.4) 33 (54.1)
Not sure 160 (41.9) 18 (20.0) 30 (45.5) 16 (26.2)
Missing 16 (4.2) 1 (1.1) 0 (0) 0 (0)
d. Kidney problems
*Yes 243 (73.8) 45 (100.0) 37 (56.1) 45 (73.8)
No 14 (4.2) 0 (0) 6 (9.1) 6 (9.8)
Not sure 63 (19.1) 0 (0) 23 (34.8) 10 (16.4)
Missing 9 (2.7) 0 (0) 0 (0) 0 (0)
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Page 7 of 12medicine (ICC = 0.72), avoid prescription medicine (ICC
=0 . 7 5 ) ,a n da v o i dc o s t s( I C C=0 . 7 2 ) .O n eg o a l ,a v o i d
long recovery, had lower retest reliability (ICC = 0.55).
Validity of DQI-Knowledge Score
(1) Discriminant validity: In study 1, the retrospective
study, the mean knowledge scores were 61% (SD 21%)
for patients and 78% (SD 14%) for providers. The
knowledge scores discriminated significantly between
providers and patients (mean difference 19%, 95%CI
(13% to 25%), p < 0.001) for knee and 15%, 95%CI (9%
to 21%) for hip p < 0.001). Study 2, the randomized
trial, also demonstrated discriminant validity, as patients
in the decision aid group were significantly more knowl-
edgeable than those in usual care group (68% (SD 18%)
versus 54% (SD 19%), mean difference 14%, 95%CI (8%
to 21%), p < 0.001). Table 2 presents the distribution of
responses for each knowledge item across the samples.
(2) Content validity: The majority of providers felt that
the set of knowledge items covered the key facts extre-
mely or very well (71%), confirming content validity. On
average, 75% of providers considered the individual
items essential for patients to know (range 50% for side
effects of medicines to 92% for likelihood of serious
complications after surgery).
Validity of DQI-Concordance Score
(1) Content validity of goals: The percentage of patients
selecting each goal as one of their top three varied
depending on their treatment. For surgical patients, 97%
selected “relieve pain” and 96% selected “not be limited
in what you can do” as one of their top three issues.
T h o s ew e r ef o l l o w e db y“avoid prescription medicine”
(44%) and “avoid long recovery time” (28%). Many non-
surgical patients also selected “relieve pain” (78%) and
“not be limited in what you can do” (76%), followed by
“avoid long recovery time” (59%), “avoid surgery” (41%),
and “avoid prescription medicine” (24%). Two goals did
not have strong content validity based on low frequency
of selection: “avoid over the counter medicine” (14% and
5%) and “avoid costs” (6% and 9%) for surgical and non-
surgical patients respectively.
(2) Discriminant validity: Four of the seven goals dis-
criminated significantly between those who had surgery
and those who did not have surgery (see Table 3, uni-
variate results). Two goals remained significant
Table 3 Univariate (t-test or chi-squared) and multivariable logistic regression analyses of factors associated with
treatment received using data from study
Surgery Non-surgical Univariate Multivariable
Factor N = 235 N = 147 p Odds ratio of surgery 95% CI
Age (mean years) 62.7 62.7 0.95 1.02 0.99, 1.05
Education (% college graduate) 61.0 49.0 0.02 1.46 0.85, 2.51
Gender (% female) 55.8 56.5 0.83 1.20 0.71, 2.04
Joint (% Knee) 43.8 66.7 <0.0001 0.35 0.20, 0.60
On a scale of 0 to 10, how important is it to you to...
Relieve pain 9.5 8.5 <0.0001 1.21 0.98, 1.48
Not be limited in what you can do 9.8 8.9 <0.0001 1.58 1.18, 2.11
Avoid surgery 3.9 6.7 <0.0001 0.81 0.75, 0.88
Avoid over the counter medicine 5.4 4.9 0.22 1.05 0.95, 1.16
Avoid prescription medicine 6.2 5.8 0.33 1.02 0.93, 1.13
Avoid long recovery time 7.5 8.1 0.03 0.94 0.85, 1.05
Avoid costs of surgery 3.7 4.2 0.24 0.98 0.91, 1.06
1. Factors that are bolded were significant in the regression model and were used to calculate the concordance score.
Table 2 Distribution of responses to the Hip and Knee Osteoarthritis Decision Quality Instruments for patients and
providers across the two studies. (Continued)
e. Excessive bleeding
*Yes 243 (73.8) 85 (94.4) 37 (56.1) 40 (65.6)
No 13 (3.9) 3 (3.3) 8 (12.1) 14 (23.0)
Not sure 63 (19.1) 0 (0) 21 (31.8) 7 (11.5)
Missing 9 (2.7) 1 (1.1) 0 (0) 0 (0)
Knowledge items reprinted with permission from the Hip Osteoarthritis Decision Quality Instrument and the Hip Osteoarthritis Decision Quality Instrument
©Massachusetts General Hospital, 2010.
*Indicates the correct answer.
**Providers (n = 45) completed both the hip and knee instruments and the distributions here combine their responses.
†Indicates those items included in the HK-DQI Screener version.
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hip) in multivariable logistic regression (see Table 3,
multivariable results). Respondents who felt strongly
about the importance of “not being limited in what you
can do” were more likely to have surgery (OR 1.58 95%
CI(1.18, 2.11), p < 0.001) and those who felt strongly
about importance of “avoiding surgery” were less likely
to have surgery (0.81 95%CI(0.75, 0.88), p < 0.001). The
majority of patients in study 1 (73%) received treatment
which matched that predicted by the regression model.
Many non-surgical patients (41%) appeared to prefer
surgery, an option that they may pursue in the future.
Some patients who had surgery (18%) had scores that
suggest a preference for non-surgical treatment.
The regression model of treatment received had
acceptable predictive accuracy (c-statistic = 0.81, Table
3). The predicted probability generated by the model
also discriminated well among patients who stated a
preference for surgery, those who were unsure, and
those who preferred non-surgical approaches. Patients
who stated a treatment preference for surgery had a sig-
nificantly higher mean predicted probability of surgery
compared to patients who were unsure (0.74 vs. 0.59, p
< 0.001). Patients who were unsure had a significantly
higher mean predicted probability compared to those
who stated a preference for non-surgical approaches
(0.59 vs. 0.40, p < 0.001).
(3) Predictive validity: Patients who were concordant
(i.e. had treatment that “matched” that predicted by the
regression model) had higher confidence in their deci-
sion (8.7/10 vs. 8.0/10, p = 0.03) and were more likely
to definitely want to do the same thing again compared
to those who had treatment that did not match that pre-
dicted by the regression model (68% vs. 52%, p = 0.01).
HK-DQI-Screener
A shorter version, HK-DQI-screener, contained 5
knowledge items and 5 goals (see Table 2). The mean
knowledge scores discriminated between patients in the
decision aid group 67% (SD 21.2) compared to 51% (SD
24.9) in the usual care group (p < 0.001). The screener
knowledge score demonstrated high reproducibility with
t h et o t a lD Q I - K n o w l e d g eS core (Pearson correlation
coefficients of 0.92 and 0.95 for studies 1 and 2 respec-
tively, p < 0.001 for both).
Discussion
The HK-DQI is specifically designed to evaluate deci-
sion quality for patients considering total joint replace-
ment. The HK-DQI results in two scores, a total
knowledge score that can be used to assess the extent
to which patients are informed and a concordance score
that can be used to assess the extent to which a group
of patients received treatments that match their goals.
The instrument meets many of the criteria for high
quality, patient reported surveys. The instrument is
acceptable to patients based on high response rates. It
is also feasible to implement either over the phone or
by the patient alone with few missing items and takes
about 5 minutes to complete. It can discriminate
between those who have different levels of knowledge
and has high content validity, as both providers and
patients felt it covered content that is essential for deci-
sions about treatment of osteoarthritis. The concor-
dance score discriminated among patients who
preferred different treatment options. In addition,
patients who received treatment that “matched” their
goals had more confidence and less regret about their
decision.
The results can be used to generate guidelines for
what level of knowledge test score is needed for
“informed” patients. A reasonable approach would be to
use the mean score of patients who have viewed a deci-
sion aid (68% or higher) as a target. The difference
between patients in the decision aid group compared to
the usual care group of 14.1 points out of 100 is similar
to that found in the Cochrane Systematic Review’s
meta-analysis of knowledge test scores of the 55 rando-
mized controlled trials evaluating patient decision aids
of 15.18 (95% CI: 11.66, 18.69) for the same comparison
groups [15]. Alternatively, clinicians may use the knowl-
edge instrument for quality improvement efforts, where
the goal would be to measure patients’ understanding of
the key facts during the decision making process and
increase scores over time.
The concordance score provides a means of measur-
ing the extent to which treatment for osteoarthritis is
tailored to patients’ goals. Two goals remained signifi-
cant predictors in the multivariate model, how patients
felt about improving their functional status and their
concern about having surgery. Often, the appropriate-
ness of treatments like TJR is determined by severity of
standard patient reported outcomes such as pain, symp-
tom or functional status. Studies show that patients vary
widely in their response to same level of symptoms [14].
This finding underscores the importance of assessing
the level of bother for their symptoms, also referred to
as patients’ utilities, in addition to symptom severity.
Patients who are very bothered by their pain or func-
tional status should be more likely to have surgery (even
if the level of symptoms is moderate). And, those who
are very bothered by the prospect of surgery, should be
less likely to have it (even if their level of symptoms are
severe). A study of more than 2,000 men and women
with osteoarthritis found that “willingness to consider
replacement” was the biggest predictor of time to knee
replacement, almost five times more influential than the
pain score [16].
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interpreted carefully. Patients were reporting their goals
about one year after the decision, and the assessment
might have differed closer to the time of decision mak-
ing. Research on patients’ decision making has repeat-
edly found that preferences can change with
information, with experience, and they can change over
time [17-19]. The regression model generates population
level weights for the two goals in order to best predict
treatment, and individuals may have different weight-
ings. Patients in our study emphasized importance of
additional issues, and other studies have shown that
patients do consider other issues including pain, recov-
ery time, and costs when deciding about TJR [20-22].
Despite these limitations, the regression model was able
to discriminate well among patients who stated different
treatment preferences supporting the validity of the con-
cordance score. Additional research to understand
whether and how patients’ goals change over time, and
to examine generalizability of the concordance model is
needed.
There are two main ways that we envision the HK-
DQI being used. The first is as a means to audit the
quality of decisions for hospitals or orthopedic prac-
tices. For this purpose, patients who have recently
made decisions about treatment of osteoarthritis (sur-
gical and non-surgical approaches) may be surveyed to
assess their level of understanding and their goals. To
increase the practicality of the survey, a sample of
patients might be surveyed periodically, e.g., all
patients who had consulted a specialist about joint
replacement surgery in the past six months. Study 1,
that surveyed patients who had recently made a deci-
sion, replicated this type of sampling. The results of
the survey can be used to determine patients’ under-
standing of their options, and to document the extent
to which treatments are tailored to patients’ goals. An
earlier version of these items was used this way in a
national study of decision making, the DECISIONS
study, which found fairly low knowledge and variable
patient participation in decisions about surgery for
osteoarthritis [23].
The HK-DQI (or the shorter screener version) could
also be used in clinical practice as a screening tool.
Patients could be surveyed in advance of a clinic visit to
identify knowledge gaps and to elicit goals for incor-
poration into treatment recommendations [7]. This type
of use requires significant integration into clinic pro-
cesses to get the survey to appropriate patients in
advance of the visit. For organizations that have adopted
health information technology to collect patient
reported outcomes, adding questions to assess patients’
knowledge and their goals and concerns may be fairly
straightforward. This approach can also be tied to
provision of decision support, such as patient decision
aids, as is happening at a few hospitals across the coun-
try [24]. Surgeons who are provided with patients’
responses to the HK-DQI may find that their encounter
with a patient is more efficient, allowing discussion to
address gaps in knowledge and to examine stated goals
and patient concerns.
A more systematic approach to documenting patients’
knowledge and goals may result in improvements
in care. Mancuso found that patients had many expec-
tations about joint replacement surgery, and only 43%
of patients had all their expectations completely met
[25]. Further, if providers and organizations have a
means of documenting that decisions are based on
patients’ informed values for outcomes of options, then
they will be able to demonstrate that they are meeting
standards for informed consent as well as new priori-
ties set out in the healthcare reform legislation in the
U.S. [4,26,27].
These two studies provide complementary evidence on
the applicability of the HK-DQI for different populations
(United States and Canada) and at different time points
(for patients about one year after the decision and for
patients currently facing the decision). However, there
are several limitations to be considered. Data are lacking
that would enable generalizability of the HK-DQI for
non-White populations and those with limited literacy.
Further, the knowledge items cover knowledge of key
facts, but do not test higher level comprehension of the
information. As mentioned earlier, study 1 was retro-
spective and may not accurately reflect patients’ knowl-
edge or goals at the time of the decision. Study 2, which
did survey patients at the time of decision making, did
not have sufficient number of patients selecting non-
surgical options to be able to use those data to con-
struct the concordance model. In future research, it will
be important to validate the concordance model with a
sample of patients facing the decision.
Conclusions
In summary, the HK-DQI is a patient self-reported sur-
vey instrument that can be used to measure the quality
of decisions about total joint replacement for knee or
hip osteoarthritis. It results in two scores, a knowledge
s c o r et om e a s u r eh o wi n f o r m e dp a t i e n t sa r ea n dac o n -
cordance score to indicate the extent to which patients
received treatments that matched their goals. The
instrument fills an important gap in the literature and
may contribute to efforts to measure shared decision
making and the delivery of patient-centered care.
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